Enanta Pharmaceuticals Inc (ENTA)
SG&A Expense Growth
-1.03%
Quarterly · Period ending:
ENTA SG&A Expense Growth
Latest reported-1.03%period ending
Latest reported-1.03%period ending
ENTA Quarterly SG&A Growth (QoQ) (0.00% → -1.03%)
Latest values, visible window
High-resolution chart · PNG
ENTA sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -1.0347% | |
| 6.2049% | |
| -7.1429% | |
| -2.9509% | |
| -12.2146% | |
| -11.3498% | |
| -6.1171% | |
| 2.0054% | |
| -5.7675% | |
| -13.8213% | |
| 19.739% | |
| 9.3279% | |
| -4.6835% | |
| 8.6418% | |
| 2.2746% | |
| -2.4482% | |
| 16.5808% | |
| 10.1809% | |
| 13.7865% | |
| -1.4274% | |
| 1.8136% | |
| 12.8643% | |
| 9.6463% | |
| -1.3923% | |
| -0.8861% | |
| -0.5346% | |
| 12.2992% | |
| 0.1951% | |
| -9.2773% | |
| -5.2013% | |
| 22.6758% | |
| -4.9715% | |
| 7.5184% | |
| -1.1092% | |
| 12.7394% | |
| -2.1976% | |
| -4.1751% | |
| 10.6137% | |
| 11.1937% | |
| 3.6899% | |
| -3.2535% | |
| 15.9246% | |
| 3.3848% | |
| 1.3725% | |
| 5.9628% | |
| 24.1603% | |
| 0.2898% | |
| 6.0699% | |
| 1.4815% | |
| 22.9037% | |
| 19.2571% | |
| -2.1253% | |
| 33.234% | |
| 16.4931% | |
| -34.9887% | |
| 54.7598% | |
| -5.1367% | |
| -3.5172% | |
| 4.0765% | |
| 0% |